Form 4 for AGL agilon health, inc.
Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-01 · accession 0001628280-25-016683 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-03 | 2025-04-01 | AGL | Zamore Denise | CLO | A - Grant | $0.00 | +245.1K | 450.0K | +120% | $0 |
| D | 2025-04-03 | 2025-04-01 | AGL | Zamore Denise | CLO | A - Grant | $0.00 | +384.6K | 384.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | A | A | 245,099 | $0.00 | 450,047 | D | — | — | (F1) Restricted stock units that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment. (F2) Includes Performance Stock Units which may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date. (F3) Includes restricted stock units. |
| 2 | Derivative | Options (Right to buy) | 2025-04-01 | A | A | 384,616 | $0.00 | 384,616 | D | $4.08 · — to 2035-04-01 | 384,616 Common Stock | (F4) Options that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment. |